(secondQuint)A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection.

 The study has 3 parts.

 Part A is a single ascending dose (SAD) study in healthy volunteers.

 Part B is a single ascending dose study (SAD) in patients with HBV infection.

 Part C is a multiple ascending dose study (MAD) in patients with HBV infection.

.

 A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection@highlight

The purpose of this study is to determine the safety, tolerability and pharmacokinetics of ALN-HBV in healthy adult volunteers and patients with chronic hepatitis B virus (HBV) infection.

 In addition, the study will assess antiviral efficacy of ALN-HBV in patients with HBV.

